ID

13887

Descrizione

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance; ODM derived from: https://clinicaltrials.gov/show/NCT01240252

collegamento

https://clinicaltrials.gov/show/NCT01240252

Keywords

versioni (1)
  1. 13/03/16 13/03/16 -
Caricato su

13 marzo 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 2 Diabetes Mellitus NCT01240252

Inglese

Eligibility Type 2 Diabetes Mellitus NCT01240252

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 30-65 y
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
healthy lean, obese, or known type 2 diabetic
Descrizione

diabetes mellitus type 2

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
body mass index (bmi) less than 36
Descrizione

body mass index

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1305855
all nondiabetic subjects must have normal oral glucose tolerance
Descrizione

Oral Glucose Tolerance Test

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0029161
subjects must have the following laboratory values:
Descrizione

laboratory parameters

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022885
1. hematocrit ≥ 35 vol%
Descrizione

hematocrit

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0518014
2. serum creatinine ≤ 1.6 mg/dl
Descrizione

serum creatinine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
3. aspartate aminotransferase (ast) (sgot)< 2 times upper limit of normal
Descrizione

aspartate aminotransferase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201899
4. alanine aminotransferase (alt) (sgpt)< 2 times upper limit of normal
Descrizione

alanine aminotransferase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201836
5. alkaline phosphatase < 2 times upper limit of normal
Descrizione

alkaline phosphatase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201850
6. triglycerides < 150 mg/dl
Descrizione

triglycerides

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0202236
7. prothrombin time (pt) 11.7 -14.3 seconds
Descrizione

prothrombin time

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0491338
8. partial thromboplastin time 23.0-37.0 seconds
Descrizione

partial thromboplastin time

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3525810
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
no diseases known to affect glucose metabolism other than healthy type 2 diabetes
Descrizione

glucose metabolism; diabetes mellitus type 2

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0596620
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C0441730
subjects must not be receiving any of the following medications: thiazide or furosemide diuretics, beta-blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless the patient has been on stable dose of such agents for the past three months before entry into the study. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months. subjects taking systemic glucocorticoids are excluded.
Descrizione

Thiazide Diuretics; beta-blockers; estrogens therapy; systemic glucocorticoids

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0012802
UMLS CUI [2]
C0001645
UMLS CUI [3]
C3541386
UMLS CUI [4]
C3540777
subjects with a history of clinically significant heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg), peripheral vascular disease (history of claudication), or pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation) will not be studied.
Descrizione

heart disease; nyha classification; peripheral vascular disease; pulmonary disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C1275491
UMLS CUI [3]
C0085096
UMLS CUI [4]
C0024115
recent systemic or pulmonary embolus, untreated high-risk proliferative retinopathy, recent retinal hemorrhage, uncontrolled hypertension, systolic bp>180, diastolic bp>105, autonomic neuropathy, resting heart rate >100, electrolyte abnormalities.
Descrizione

Pulmonary Embolism; retinopathy; retinal hemorrhage; uncontrolled hypertension; blood pressure; neuropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0034065
UMLS CUI [2]
C0035309
UMLS CUI [3]
C0035317
UMLS CUI [4]
C1868885
UMLS CUI [5]
C0005823
UMLS CUI [6]
C0442874
Ritorna all'inizio della pagina

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01240252

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age 30-65 y
boolean
C0001779 (UMLS CUI [1])
diabetes mellitus type 2
Item
healthy lean, obese, or known type 2 diabetic
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
body mass index
Item
body mass index (bmi) less than 36
boolean
C1305855 (UMLS CUI [1])
Oral Glucose Tolerance Test
Item
all nondiabetic subjects must have normal oral glucose tolerance
boolean
C0029161 (UMLS CUI [1])
laboratory parameters
Item
subjects must have the following laboratory values:
boolean
C0022885 (UMLS CUI [1])
hematocrit
Item
1. hematocrit ≥ 35 vol%
boolean
C0518014 (UMLS CUI [1])
serum creatinine
Item
2. serum creatinine ≤ 1.6 mg/dl
boolean
C0201976 (UMLS CUI [1])
aspartate aminotransferase
Item
3. aspartate aminotransferase (ast) (sgot)< 2 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
alanine aminotransferase
Item
4. alanine aminotransferase (alt) (sgpt)< 2 times upper limit of normal
boolean
C0201836 (UMLS CUI [1])
alkaline phosphatase
Item
5. alkaline phosphatase < 2 times upper limit of normal
boolean
C0201850 (UMLS CUI [1])
triglycerides
Item
6. triglycerides < 150 mg/dl
boolean
C0202236 (UMLS CUI [1])
prothrombin time
Item
7. prothrombin time (pt) 11.7 -14.3 seconds
boolean
C0491338 (UMLS CUI [1])
partial thromboplastin time
Item
8. partial thromboplastin time 23.0-37.0 seconds
boolean
C3525810 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
glucose metabolism; diabetes mellitus type 2
Item
no diseases known to affect glucose metabolism other than healthy type 2 diabetes
boolean
C0596620 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0441730 (UMLS CUI [2,2])
Thiazide Diuretics; beta-blockers; estrogens therapy; systemic glucocorticoids
Item
subjects must not be receiving any of the following medications: thiazide or furosemide diuretics, beta-blockers, or other chronic medications with known adverse effects on glucose tolerance levels unless the patient has been on stable dose of such agents for the past three months before entry into the study. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months. subjects taking systemic glucocorticoids are excluded.
boolean
C0012802 (UMLS CUI [1])
C0001645 (UMLS CUI [2])
C3541386 (UMLS CUI [3])
C3540777 (UMLS CUI [4])
heart disease; nyha classification; peripheral vascular disease; pulmonary disease
Item
subjects with a history of clinically significant heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg), peripheral vascular disease (history of claudication), or pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation) will not be studied.
boolean
C0018799 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
C0085096 (UMLS CUI [3])
C0024115 (UMLS CUI [4])
Pulmonary Embolism; retinopathy; retinal hemorrhage; uncontrolled hypertension; blood pressure; neuropathy
Item
recent systemic or pulmonary embolus, untreated high-risk proliferative retinopathy, recent retinal hemorrhage, uncontrolled hypertension, systolic bp>180, diastolic bp>105, autonomic neuropathy, resting heart rate >100, electrolyte abnormalities.
boolean
C0034065 (UMLS CUI [1])
C0035309 (UMLS CUI [2])
C0035317 (UMLS CUI [3])
C1868885 (UMLS CUI [4])
C0005823 (UMLS CUI [5])
C0442874 (UMLS CUI [6])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial